25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Shanghai No1 Pharmacy Co Ltd
Buy, Hold or Sell?

Let's analyze Shanghai No1 Pharmacy Co Ltd together

I guess you are interested in Shanghai No1 Pharmacy Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai No1 Pharmacy Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Shanghai No1 Pharmacy Co Ltd

I send you an email if I find something interesting about Shanghai No1 Pharmacy Co Ltd.

1. Quick Overview

1.1. Quick analysis of Shanghai No1 Pharmacy Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Shanghai No1 Pharmacy Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
82.5%

What is your share worth?

Current worth
¥4.90
Expected worth in 1 year
¥5.26
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
¥0.50
Return On Investment
3.5%

For what price can you sell your share?

Current Price per Share
¥14.35
Expected price per share
¥11.55 - ¥15.64
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Shanghai No1 Pharmacy Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥14.35
Intrinsic Value Per Share
¥-9.97 - ¥-1.67
Total Value Per Share
¥-5.07 - ¥3.23

2.2. Growth of Shanghai No1 Pharmacy Co Ltd (5 min.)




Is Shanghai No1 Pharmacy Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$153.7m$134.7m$11.4m7.9%

How much money is Shanghai No1 Pharmacy Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$6m$5.4m$598.8k9.8%
Net Profit Margin9.7%5.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Shanghai No1 Pharmacy Co Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  


Richest
#17 / 41

Most Revenue
#28 / 41

Most Profit
#15 / 41
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Shanghai No1 Pharmacy Co Ltd?

Welcome investor! Shanghai No1 Pharmacy Co Ltd's management wants to use your money to grow the business. In return you get a share of Shanghai No1 Pharmacy Co Ltd.

First you should know what it really means to hold a share of Shanghai No1 Pharmacy Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shanghai No1 Pharmacy Co Ltd is ¥14.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai No1 Pharmacy Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai No1 Pharmacy Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.90. Based on the TTM, the Book Value Change Per Share is ¥0.09 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai No1 Pharmacy Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.060.4%0.030.2%0.010.1%0.010.1%0.010.1%
Usd Book Value Change Per Share0.030.2%0.010.1%0.030.2%0.010.1%0.010.1%
Usd Dividend Per Share0.020.1%0.000.0%0.020.2%0.010.1%0.010.0%
Usd Total Gains Per Share0.050.3%0.020.1%0.050.4%0.020.1%0.020.1%
Usd Price Per Share1.47-1.58-1.63-1.48-1.81-
Price to Earnings Ratio6.22-24.62-34.97-39.13-62.41-
Price-to-Total Gains Ratio30.77-269.63-37.93-21.18--21.86-
Price to Book Ratio2.13-2.42-2.69-2.76-3.73-
Price-to-Total Gains Ratio30.77-269.63-37.93-21.18--21.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.02048
Number of shares494
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.020.02
Gains per Quarter (494 shares)8.629.42
Gains per Year (494 shares)34.4937.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
192524162128
2195058324366
32875924964104
4381001266586142
54712516081107180
65715019497129218
766175228113150256
875200262129172294
985226296146193332
1094251330162215370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%89.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%13.07.00.065.0%25.015.00.062.5%64.025.00.071.9%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%33.00.07.082.5%53.00.036.059.6%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%14.06.00.070.0%27.013.00.067.5%67.022.00.075.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Shanghai No1 Pharmacy Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2100.090+133%0.203+3%0.077+171%0.059+258%
Book Value Per Share--4.8964.654+5%4.288+14%3.831+28%3.528+39%
Current Ratio--1.6811.651+2%1.415+19%1.607+5%1.051+60%
Debt To Asset Ratio--0.4330.447-3%0.533-19%0.463-6%0.420+3%
Debt To Equity Ratio--0.7710.815-5%1.191-35%0.905-15%0.760+1%
Dividend Per Share--0.1300.034+283%0.176-26%0.058+123%0.048+168%
Eps--0.4200.194+116%0.101+317%0.098+329%0.074+466%
Free Cash Flow Per Share---0.184-0.255+38%0.711-126%0.061-403%0.109-268%
Free Cash Flow To Equity Per Share---0.184-0.255+38%-0.598+225%-0.113-38%0.015-1367%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.667--------
Intrinsic Value_10Y_min---9.969--------
Intrinsic Value_1Y_max--0.351--------
Intrinsic Value_1Y_min---0.032--------
Intrinsic Value_3Y_max--0.659--------
Intrinsic Value_3Y_min---0.935--------
Intrinsic Value_5Y_max--0.492--------
Intrinsic Value_5Y_min---2.749--------
Market Cap3201284100.000+27%2331252326.1502508048256.148-7%2584455329.995-10%2339506355.4700%2872289758.235-19%
Net Profit Margin--0.2170.097+124%0.057+278%0.054+304%0.043+403%
Operating Margin----0%0.022-100%0.022-100%0.013-100%
Operating Ratio--1.8641.822+2%1.734+8%1.784+4%1.430+30%
Pb Ratio2.931+27%2.1342.422-12%2.690-21%2.762-23%3.729-43%
Pe Ratio8.538+27%6.21824.619-75%34.965-82%39.126-84%62.407-90%
Price Per Share14.350+27%10.45011.243-7%11.585-10%10.4870%12.875-19%
Price To Free Cash Flow Ratio-19.497-37%-14.198-8.143-43%5.831-344%7.095-300%34.747-141%
Price To Total Gains Ratio42.257+27%30.773269.632-89%37.930-19%21.184+45%-21.856+171%
Quick Ratio--0.4880.518-6%0.506-3%0.386+26%0.402+22%
Return On Assets--0.0490.023+113%0.019+160%0.014+236%0.012+302%
Return On Equity--0.0860.041+110%0.042+107%0.028+207%0.022+293%
Total Gains Per Share--0.3400.124+174%0.379-10%0.135+151%0.107+217%
Usd Book Value--153788991.768146193747.513+5%134702097.144+14%120325083.266+28%110830049.123+39%
Usd Book Value Change Per Share--0.0300.013+133%0.029+3%0.011+171%0.008+258%
Usd Book Value Per Share--0.6890.655+5%0.604+14%0.539+28%0.497+39%
Usd Dividend Per Share--0.0180.005+283%0.025-26%0.008+123%0.007+168%
Usd Eps--0.0590.027+116%0.014+317%0.014+329%0.010+466%
Usd Free Cash Flow---5779672.417-7999179.698+38%22325040.480-126%1909103.545-403%3436551.488-268%
Usd Free Cash Flow Per Share---0.026-0.036+38%0.100-126%0.009-403%0.015-268%
Usd Free Cash Flow To Equity Per Share---0.026-0.036+38%-0.084+225%-0.016-38%0.002-1367%
Usd Market Cap450740801.280+27%328240327.522353133194.466-7%363891310.463-10%329402494.8500%404418397.959-19%
Usd Price Per Share2.020+27%1.4711.583-7%1.631-10%1.4770%1.813-19%
Usd Profit--13197929.5706097863.922+116%5499036.473+140%3544516.085+272%2566693.112+414%
Usd Revenue--60698573.96063868407.368-5%91750242.915-34%63216833.000-4%56448196.608+8%
Usd Total Gains Per Share--0.0480.017+174%0.053-10%0.019+151%0.015+217%
 EOD+5 -3MRQTTM+27 -7YOY+20 -155Y+24 -1110Y+23 -12

3.3 Fundamental Score

Let's check the fundamental score of Shanghai No1 Pharmacy Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-158.538
Price to Book Ratio (EOD)Between0-12.931
Net Profit Margin (MRQ)Greater than00.217
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.488
Current Ratio (MRQ)Greater than11.681
Debt to Asset Ratio (MRQ)Less than10.433
Debt to Equity Ratio (MRQ)Less than10.771
Return on Equity (MRQ)Greater than0.150.086
Return on Assets (MRQ)Greater than0.050.049
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Shanghai No1 Pharmacy Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose14.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Shanghai No1 Pharmacy Co Ltd

Shanghai No.1 Pharmacy Co.,Ltd. engages in the retail and wholesale of pharmaceutical products. The company offers products in the categories of Chinese and Western medicines, nutrition and health products, medical equipment, Chinese herbal medicines, etc. In addition, it provides consulting and guidance on safe medication, rational medication, and chronic disease medication. Shanghai No. 1 Pharmacy Co.,Ltd. was founded in 1992 and is based in Shanghai, China.

Fundamental data was last updated by Penke on 2024-10-30 13:41:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Shanghai No1 Pharmacy Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai No1 Pharmacy Co Ltd to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of 21.7% means that ¥0.22 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 21.7%. The company is making a huge profit. +2
  • The TTM is 9.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ21.7%TTM9.7%+12.0%
TTM9.7%YOY5.7%+3.9%
TTM9.7%5Y5.4%+4.3%
5Y5.4%10Y4.3%+1.1%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ21.7%1.0%+20.7%
TTM9.7%0.7%+9.0%
YOY5.7%1.0%+4.7%
5Y5.4%1.6%+3.8%
10Y4.3%1.5%+2.8%
4.3.1.2. Return on Assets

Shows how efficient Shanghai No1 Pharmacy Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai No1 Pharmacy Co Ltd to the Pharmaceutical Retailers industry mean.
  • 4.9% Return on Assets means that Shanghai No1 Pharmacy Co Ltd generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 4.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.9%TTM2.3%+2.6%
TTM2.3%YOY1.9%+0.4%
TTM2.3%5Y1.4%+0.8%
5Y1.4%10Y1.2%+0.2%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%0.4%+4.5%
TTM2.3%0.4%+1.9%
YOY1.9%0.3%+1.6%
5Y1.4%0.3%+1.1%
10Y1.2%0.3%+0.9%
4.3.1.3. Return on Equity

Shows how efficient Shanghai No1 Pharmacy Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai No1 Pharmacy Co Ltd to the Pharmaceutical Retailers industry mean.
  • 8.6% Return on Equity means Shanghai No1 Pharmacy Co Ltd generated ¥0.09 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 8.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ8.6%TTM4.1%+4.5%
TTM4.1%YOY4.2%-0.1%
TTM4.1%5Y2.8%+1.3%
5Y2.8%10Y2.2%+0.6%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6%1.4%+7.2%
TTM4.1%1.0%+3.1%
YOY4.2%1.6%+2.6%
5Y2.8%1.8%+1.0%
10Y2.2%0.8%+1.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Shanghai No1 Pharmacy Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Shanghai No1 Pharmacy Co Ltd is operating .

  • Measures how much profit Shanghai No1 Pharmacy Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai No1 Pharmacy Co Ltd to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.2%-2.2%
TTM-5Y2.2%-2.2%
5Y2.2%10Y1.3%+0.9%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.7%-2.7%
TTM-1.4%-1.4%
YOY2.2%1.5%+0.7%
5Y2.2%1.4%+0.8%
10Y1.3%1.3%+0.0%
4.3.2.2. Operating Ratio

Measures how efficient Shanghai No1 Pharmacy Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 1.86 means that the operating costs are ¥1.86 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 1.864. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.822. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.864TTM1.822+0.042
TTM1.822YOY1.734+0.089
TTM1.8225Y1.784+0.038
5Y1.78410Y1.430+0.355
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8641.493+0.371
TTM1.8221.246+0.576
YOY1.7341.147+0.587
5Y1.7841.174+0.610
10Y1.4301.185+0.245
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Shanghai No1 Pharmacy Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Shanghai No1 Pharmacy Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 1.68 means the company has ¥1.68 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 1.681. The company is able to pay all its short-term debts. +1
  • The TTM is 1.651. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.681TTM1.651+0.029
TTM1.651YOY1.415+0.236
TTM1.6515Y1.607+0.044
5Y1.60710Y1.051+0.556
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6811.259+0.422
TTM1.6511.270+0.381
YOY1.4151.161+0.254
5Y1.6071.315+0.292
10Y1.0511.443-0.392
4.4.3.2. Quick Ratio

Measures if Shanghai No1 Pharmacy Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai No1 Pharmacy Co Ltd to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.49 means the company can pay off ¥0.49 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 0.488. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.518. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.488TTM0.518-0.030
TTM0.518YOY0.506+0.013
TTM0.5185Y0.386+0.132
5Y0.38610Y0.402-0.016
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4880.505-0.017
TTM0.5180.546-0.028
YOY0.5060.536-0.030
5Y0.3860.641-0.255
10Y0.4020.881-0.479
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Shanghai No1 Pharmacy Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Shanghai No1 Pharmacy Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai No1 Pharmacy Co Ltd to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.43 means that Shanghai No1 Pharmacy Co Ltd assets are financed with 43.3% credit (debt) and the remaining percentage (100% - 43.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 0.433. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.447. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.433TTM0.447-0.014
TTM0.447YOY0.533-0.086
TTM0.4475Y0.463-0.015
5Y0.46310Y0.420+0.042
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4330.638-0.205
TTM0.4470.651-0.204
YOY0.5330.690-0.157
5Y0.4630.640-0.177
10Y0.4200.600-0.180
4.5.4.2. Debt to Equity Ratio

Measures if Shanghai No1 Pharmacy Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai No1 Pharmacy Co Ltd to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 77.1% means that company has ¥0.77 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai No1 Pharmacy Co Ltd:

  • The MRQ is 0.771. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.815. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.771TTM0.815-0.044
TTM0.815YOY1.191-0.376
TTM0.8155Y0.905-0.090
5Y0.90510Y0.760+0.145
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7711.607-0.836
TTM0.8151.745-0.930
YOY1.1912.145-0.954
5Y0.9051.982-1.077
10Y0.7601.661-0.901
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanghai No1 Pharmacy Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shanghai No1 Pharmacy Co Ltd to the Pharmaceutical Retailers industry mean.
  • A PE ratio of 6.22 means the investor is paying ¥6.22 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai No1 Pharmacy Co Ltd:

  • The EOD is 8.538. Based on the earnings, the company is underpriced. +1
  • The MRQ is 6.218. Based on the earnings, the company is cheap. +2
  • The TTM is 24.619. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD8.538MRQ6.218+2.320
MRQ6.218TTM24.619-18.402
TTM24.619YOY34.965-10.346
TTM24.6195Y39.126-14.506
5Y39.12610Y62.407-23.282
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD8.53810.142-1.604
MRQ6.21812.431-6.213
TTM24.6199.431+15.188
YOY34.96511.917+23.048
5Y39.1266.490+32.636
10Y62.40714.310+48.097
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai No1 Pharmacy Co Ltd:

  • The EOD is -19.497. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.198. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.143. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.497MRQ-14.198-5.299
MRQ-14.198TTM-8.143-6.055
TTM-8.143YOY5.831-13.973
TTM-8.1435Y7.095-15.238
5Y7.09510Y34.747-27.651
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-19.4972.404-21.901
MRQ-14.1982.425-16.623
TTM-8.1432.438-10.581
YOY5.8313.326+2.505
5Y7.0952.868+4.227
10Y34.7470.118+34.629
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Shanghai No1 Pharmacy Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 2.13 means the investor is paying ¥2.13 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Shanghai No1 Pharmacy Co Ltd:

  • The EOD is 2.931. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.134. Based on the equity, the company is underpriced. +1
  • The TTM is 2.422. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.931MRQ2.134+0.797
MRQ2.134TTM2.422-0.287
TTM2.422YOY2.690-0.268
TTM2.4225Y2.762-0.340
5Y2.76210Y3.729-0.967
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD2.9311.134+1.797
MRQ2.1341.284+0.850
TTM2.4221.466+0.956
YOY2.6901.299+1.391
5Y2.7621.919+0.843
10Y3.7292.980+0.749
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,927,702
Total Liabilities835,451
Total Stockholder Equity1,083,848
 As reported
Total Liabilities 835,451
Total Stockholder Equity+ 1,083,848
Total Assets = 1,927,702

Assets

Total Assets1,927,702
Total Current Assets1,117,216
Long-term Assets810,486
Total Current Assets
Cash And Cash Equivalents 343,041
Short-term Investments 85,000
Net Receivables 239,655
Inventory 333,759
Other Current Assets 59,649
Total Current Assets  (as reported)1,117,216
Total Current Assets  (calculated)1,061,103
+/- 56,113
Long-term Assets
Property Plant Equipment 227,364
Intangible Assets 40,053
Long-term Assets Other 145,372
Long-term Assets  (as reported)810,486
Long-term Assets  (calculated)412,789
+/- 397,697

Liabilities & Shareholders' Equity

Total Current Liabilities664,796
Long-term Liabilities170,655
Total Stockholder Equity1,083,848
Total Current Liabilities
Short Long Term Debt 98,825
Accounts payable 387,408
Other Current Liabilities 1,415
Total Current Liabilities  (as reported)664,796
Total Current Liabilities  (calculated)487,649
+/- 177,147
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt106,738
Long-term Liabilities  (as reported)170,655
Long-term Liabilities  (calculated)106,738
+/- 63,917
Total Stockholder Equity
Retained Earnings 560,390
Total Stockholder Equity (as reported)1,083,848
Total Stockholder Equity (calculated)560,390
+/- 523,458
Other
Capital Stock223,086
Common Stock Shares Outstanding 223,086
Net Invested Capital 1,182,674
Net Working Capital 452,420
Property Plant and Equipment Gross 227,364



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
833,598
479,139
506,076
482,761
482,818
477,554
485,169
478,386
473,795
469,726
488,687
485,078
495,274
465,404
463,781
429,016
446,210
418,353
445,352
343,664
358,722
353,561
382,720
481,150
500,968
480,811
514,779
696,569
671,769
627,787
601,138
589,109
651,968
675,916
726,405
721,571
764,112
690,350
758,459
788,179
797,856
765,621
784,772
794,206
829,831
831,457
879,171
892,268
875,796
830,148
870,479
916,163
931,130
938,418
1,012,685
1,080,980
1,156,218
1,248,373
1,178,360
1,230,135
1,138,228
1,159,068
1,157,991
1,185,287
1,253,625
1,177,703
1,162,516
1,135,968
1,112,269
1,091,399
1,098,743
1,079,466
1,246,313
1,227,010
1,194,387
1,216,552
1,478,514
1,381,764
1,396,797
1,396,256
1,245,084
1,244,487
1,258,749
1,334,463
1,353,150
2,257,031
2,278,390
2,039,102
2,098,107
1,860,121
1,863,600
1,863,169
1,855,150
1,927,702
1,927,7021,855,1501,863,1691,863,6001,860,1212,098,1072,039,1022,278,3902,257,0311,353,1501,334,4631,258,7491,244,4871,245,0841,396,2561,396,7971,381,7641,478,5141,216,5521,194,3871,227,0101,246,3131,079,4661,098,7431,091,3991,112,2691,135,9681,162,5161,177,7031,253,6251,185,2871,157,9911,159,0681,138,2281,230,1351,178,3601,248,3731,156,2181,080,9801,012,685938,418931,130916,163870,479830,148875,796892,268879,171831,457829,831794,206784,772765,621797,856788,179758,459690,350764,112721,571726,405675,916651,968589,109601,138627,787671,769696,569514,779480,811500,968481,150382,720353,561358,722343,664445,352418,353446,210429,016463,781465,404495,274485,078488,687469,726473,795478,386485,169477,554482,818482,761506,076479,139833,598
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
732,337
738,882
737,728
803,124
805,811
834,083
849,160
1,120,623
1,039,476
1,055,371
879,353
672,459
647,594
641,864
662,690
585,674
1,532,713
1,377,778
1,397,142
1,375,063
1,134,225
1,102,576
1,117,233
1,073,078
1,117,216
1,117,2161,073,0781,117,2331,102,5761,134,2251,375,0631,397,1421,377,7781,532,713585,674662,690641,864647,594672,459879,3531,055,3711,039,4761,120,623849,160834,083805,811803,124737,728738,882732,337000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
402,061
389,523
387,982
433,001
424,276
443,839
473,706
606,714
641,911
671,949
509,431
332,377
309,645
252,428
262,283
163,002
423,296
538,750
504,933
388,290
221,616
170,965
400,028
392,086
343,041
343,041392,086400,028170,965221,616388,290504,933538,750423,296163,002262,283252,428309,645332,377509,431671,949641,911606,714473,706443,839424,276433,001387,982389,523402,061000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
220,286
280,286
290,660
304,106
30,147
20,000
85,000
85,00020,00030,147304,106290,660280,286220,286000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
79,460
52,689
65,490
49,457
58,897
53,825
50,966
37,990
46,098
43,668
45,325
41,057
37,729
40,805
52,571
36,190
48,914
39,325
53,521
24,103
33,274
19,746
37,372
57,705
81,980
63,610
75,149
67,054
87,850
73,153
84,960
65,862
89,526
81,442
97,705
74,588
101,866
83,976
117,793
104,733
131,647
119,631
132,214
121,104
140,711
125,422
132,714
109,586
146,208
126,190
137,356
129,980
155,514
148,403
152,734
133,585
154,247
148,764
163,743
130,345
151,353
157,114
157,774
128,564
182,914
166,150
172,318
152,703
110,436
114,176
104,887
118,998
123,212
141,862
140,192
133,880
173,090
130,021
142,993
140,891
128,947
132,988
171,474
164,874
151,454
209,467
253,907
237,999
225,408
258,404
241,565
242,002
232,701
239,655
239,655232,701242,002241,565258,404225,408237,999253,907209,467151,454164,874171,474132,988128,947140,891142,993130,021173,090133,880140,192141,862123,212118,998104,887114,176110,436152,703172,318166,150182,914128,564157,774157,114151,353130,345163,743148,764154,247133,585152,734148,403155,514129,980137,356126,190146,208109,586132,714125,422140,711121,104132,214119,631131,647104,733117,79383,976101,86674,58897,70581,44289,52665,86284,96073,15387,85067,05475,14963,61081,98057,70537,37219,74633,27424,10353,52139,32548,91436,19052,57140,80537,72941,05745,32543,66846,09837,99050,96653,82558,89749,45765,49052,68979,460
       Other Current Assets 
14,073
2,646
2,196
3,355
1,850
1,837
1,845
1,720
811
800
1,597
2,007
1,733
2,551
3,682
1,786
1,260
1,863
2,185
1,619
2,265
1,651
38,998
3,121
2,270
2,589
4,041
5,868
4,312
3,944
5,548
5,673
4,023
5,915
10,940
6,298
10,717
6,417
11,767
4,847
5,297
6,237
5,402
9,434
9,529
17,434
12,279
6,837
4,524
5,779
7,310
6,093
10,155
10,496
5,140
15,561
8,731
8,909
10,597
12,291
13,628
4,754
10,162
17,070
16,901
12,790
5,336
3,857
4,944
10,374
16,314
10,706
6,718
7,467
4,419
20,435
15,440
14,086
13,309
13,300
8,015
7,437
7,774
20,592
34,533
81,996
58,817
43,959
126,299
12,713
67,194
77,386
64,241
59,649
59,64964,24177,38667,19412,713126,29943,95958,81781,99634,53320,5927,7747,4378,01513,30013,30914,08615,44020,4354,4197,4676,71810,70616,31410,3744,9443,8575,33612,79016,90117,07010,1624,75413,62812,29110,5978,9098,73115,5615,14010,49610,1556,0937,3105,7794,5246,83712,27917,4349,5299,4345,4026,2375,2974,84711,7676,41710,7176,29810,9405,9154,0235,6735,5483,9444,3125,8684,0412,5892,2703,12138,9981,6512,2651,6192,1851,8631,2601,7863,6822,5511,7332,0071,5978008111,7201,8451,8371,8503,3552,1962,64614,073
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
443,189
421,199
360,305
367,392
357,892
342,288
341,426
516,903
572,625
596,893
616,885
671,773
767,476
724,317
900,612
641,961
723,044
725,897
761,024
745,936
782,072
810,486
810,486782,072745,936761,024725,897723,044641,961900,612724,317767,476671,773616,885596,893572,625516,903341,426342,288357,892367,392360,305421,199443,189000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
22,879
21,328
179,311
179,962
181,267
191,831
194,889
184,985
185,033
182,060
181,667
202,714
202,915
201,329
192,308
188,484
185,696
186,364
180,104
151,585
145,350
146,300
66,957
156,140
75,132
154,284
71,928
150,173
67,653
146,734
64,852
135,802
60,151
132,082
58,256
128,438
56,739
128,996
58,611
131,637
60,307
128,518
59,322
123,670
55,228
120,705
60,854
165,294
98,732
161,575
96,780
160,397
96,314
94,874
93,397
90,472
89,231
88,309
87,327
88,245
87,167
85,962
84,919
83,768
83,133
81,975
82,282
86,197
94,068
83,223
81,687
79,781
80,421
79,153
78,580
75,413
74,755
73,590
73,495
72,469
141,865
141,544
133,283
167,978
159,528
150,274
148,836
181,093
169,718
174,627
184,934
215,360
229,656
227,364
227,364229,656215,360184,934174,627169,718181,093148,836150,274159,528167,978133,283141,544141,86572,46973,49573,59074,75575,41378,58079,15380,42179,78181,68783,22394,06886,19782,28281,97583,13383,76884,91985,96287,16788,24587,32788,30989,23190,47293,39794,87496,314160,39796,780161,57598,732165,29460,854120,70555,228123,67059,322128,51860,307131,63758,611128,99656,739128,43858,256132,08260,151135,80264,852146,73467,653150,17371,928154,28475,132156,14066,957146,300145,350151,585180,104186,364185,696188,484192,308201,329202,915202,714181,667182,060185,033184,985194,889191,831181,267179,962179,31121,32822,879
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
204,074
207,343
194,049
297,240
277,447
219,629
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000219,629277,447297,240194,049207,343204,074000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
4,454
4,344
930
4,467
1,100
4,351
4,285
4,228
4,152
4,478
4,494
4,327
4,253
4,179
5,064
2,603
5,015
1,619
1,964
2,413
81,371
3,640
81,745
3,751
80,499
3,807
78,062
3,807
77,022
643
75,628
538
74,496
0
73,132
244
75,783
3,206
74,707
3,171
73,581
3,173
72,653
3,323
71,335
2,583
69,440
2,378
68,133
3,467
66,877
66,257
66,226
61,984
61,272
60,577
59,899
59,402
58,690
57,978
57,266
59,823
58,903
57,915
57,350
57,200
56,217
55,239
55,488
53,677
52,742
1,415
50,785
50,787
49,972
49,502
48,771
48,190
47,708
46,963
46,442
46,333
45,488
44,638
43,864
43,825
43,378
42,558
41,696
41,674
40,807
40,053
40,05340,80741,67441,69642,55843,37843,82543,86444,63845,48846,33346,44246,96347,70848,19048,77149,50249,97250,78750,7851,41552,74253,67755,48855,23956,21757,20057,35057,91558,90359,82357,26657,97858,69059,40259,89960,57761,27261,98466,22666,25766,8773,46768,1332,37869,4402,58371,3353,32372,6533,17373,5813,17174,7073,20675,78324473,132074,49653875,62864377,0223,80778,0623,80780,4993,75181,7453,64081,3712,4131,9641,6195,0152,6035,0644,1794,2534,3274,4944,4784,1524,2284,2854,3511,1004,4679304,3444,45400
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
443,189
421,199
360,305
367,392
357,892
0
73,495
200,000
200,000
230,000
250,000
251,973
292,505
273,044
473,594
114,147
195,692
147,772
194,038
123,783
91,224
145,372
145,37291,224123,783194,038147,772195,692114,147473,594273,044292,505251,973250,000230,000200,000200,00073,4950357,892367,392360,305421,199443,189000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
1,137,640
879,400
364,723
317,237
314,976
306,712
312,770
302,078
294,123
286,363
302,979
295,589
302,737
269,012
265,165
226,395
240,500
208,692
233,164
110,985
123,541
114,439
140,840
235,381
256,497
230,726
260,680
303,027
304,787
288,354
288,049
274,953
300,741
295,108
338,283
319,317
338,722
300,829
345,775
352,299
363,036
334,617
359,880
364,795
374,128
359,010
384,481
392,426
379,338
337,961
363,239
380,026
385,182
368,437
393,581
430,009
442,987
443,738
436,741
447,044
419,721
411,636
425,127
449,291
472,075
454,584
424,191
421,903
413,239
440,309
437,194
409,898
485,459
479,431
482,177
484,215
732,674
647,146
638,389
646,939
498,215
507,494
505,318
556,539
520,384
1,426,109
1,424,715
1,080,424
1,095,585
848,233
856,542
854,715
809,681
835,451
835,451809,681854,715856,542848,2331,095,5851,080,4241,424,7151,426,109520,384556,539505,318507,494498,215646,939638,389647,146732,674484,215482,177479,431485,459409,898437,194440,309413,239421,903424,191454,584472,075449,291425,127411,636419,721447,044436,741443,738442,987430,009393,581368,437385,182380,026363,239337,961379,338392,426384,481359,010374,128364,795359,880334,617363,036352,299345,775300,829338,722319,317338,283295,108300,741274,953288,049288,354304,787303,027260,680230,726256,497235,381140,840114,439123,541110,985233,164208,692240,500226,395265,165269,012302,737295,589302,979286,363294,123302,078312,770306,712314,976317,237364,723879,4001,137,640
   > Total Current Liabilities 
1,101,705
845,269
337,653
298,029
286,754
287,458
289,624
286,764
278,808
271,317
287,933
280,813
287,960
254,503
250,657
226,395
240,500
208,692
233,164
110,985
123,541
114,439
140,839
235,382
256,410
230,639
260,593
257,936
270,513
262,150
272,222
260,315
275,760
266,684
305,635
284,377
298,696
275,371
312,503
314,345
328,358
304,180
331,818
338,592
342,414
324,576
335,075
336,079
327,477
290,664
310,094
319,664
325,082
303,446
311,838
340,372
336,702
310,801
324,279
323,750
322,461
308,456
328,260
352,958
365,328
365,704
334,469
341,872
342,151
384,240
380,490
355,799
405,838
404,958
422,358
422,230
672,479
590,305
581,945
597,331
380,471
391,636
395,842
444,036
398,607
1,311,445
1,322,031
926,375
941,667
687,405
695,408
676,789
635,481
664,796
664,796635,481676,789695,408687,405941,667926,3751,322,0311,311,445398,607444,036395,842391,636380,471597,331581,945590,305672,479422,230422,358404,958405,838355,799380,490384,240342,151341,872334,469365,704365,328352,958328,260308,456322,461323,750324,279310,801336,702340,372311,838303,446325,082319,664310,094290,664327,477336,079335,075324,576342,414338,592331,818304,180328,358314,345312,503275,371298,696284,377305,635266,684275,760260,315272,222262,150270,513257,936260,593230,639256,410235,382140,839114,439123,541110,985233,164208,692240,500226,395250,657254,503287,960280,813287,933271,317278,808286,764289,624287,458286,754298,029337,653845,2691,101,705
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,500
22,500
22,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000022,50022,50022,500000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,500
22,500
22,500
0
180,000
180,000
180,000
180,111
0
0
0
0
0
500,403
500,403
320,284
320,284
0
0
95,489
115,050
98,825
98,825115,05095,48900320,284320,284500,403500,40300000180,111180,000180,000180,000022,50022,50022,500000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
138,364
48,671
126,701
107,241
108,935
98,910
99,088
96,001
96,564
92,227
102,601
99,562
99,301
95,619
100,522
88,436
103,451
81,581
104,483
73,684
84,671
75,199
96,993
146,090
160,673
142,227
159,825
150,551
157,860
147,266
169,901
160,670
161,567
156,217
190,167
182,230
194,860
176,542
210,937
208,448
211,688
196,732
229,182
241,504
239,165
224,714
253,200
253,750
244,101
211,248
234,795
251,607
249,360
228,422
234,642
267,683
254,853
229,378
240,224
251,019
245,413
230,191
253,355
288,093
284,887
269,827
251,366
261,754
254,652
245,026
261,131
265,596
315,494
295,062
321,155
328,939
343,343
284,763
276,426
291,969
283,116
289,367
315,618
314,798
265,065
256,493
362,763
363,692
355,286
476,944
521,170
398,586
366,796
387,408
387,408366,796398,586521,170476,944355,286363,692362,763256,493265,065314,798315,618289,367283,116291,969276,426284,763343,343328,939321,155295,062315,494265,596261,131245,026254,652261,754251,366269,827284,887288,093253,355230,191245,413251,019240,224229,378254,853267,683234,642228,422249,360251,607234,795211,248244,101253,750253,200224,714239,165241,504229,182196,732211,688208,448210,937176,542194,860182,230190,167156,217161,567160,670169,901147,266157,860150,551159,825142,227160,673146,09096,99375,19984,67173,684104,48381,581103,45188,436100,52295,61999,30199,562102,60192,22796,56496,00199,08898,910108,935107,241126,70148,671138,364
       Other Current Liabilities 
214,394
219,380
119,377
92,568
90,749
78,948
178,691
83,143
79,074
76,880
86,482
78,901
84,659
73,134
59,235
57,389
56,979
52,261
47,771
14,801
16,370
16,740
21,346
56,792
63,237
60,912
78,268
84,885
90,153
92,384
79,821
77,145
91,693
87,967
92,968
79,647
81,336
76,329
79,066
83,397
94,170
84,948
80,136
74,588
80,749
77,362
59,375
59,829
60,876
56,916
52,799
45,557
53,222
52,524
54,695
50,189
59,349
58,923
61,555
50,231
54,549
55,765
52,404
42,365
57,941
73,377
60,603
57,618
64,999
109,714
89,722
55,618
60,782
68,814
59,028
76,194
136,353
107,634
101,221
89,317
81,487
88,036
69,487
75,275
90,033
439,665
362,817
3,781
12,585
143,089
1,809
6,742
1,706
1,415
1,4151,7066,7421,809143,08912,5853,781362,817439,66590,03375,27569,48788,03681,48789,317101,221107,634136,35376,19459,02868,81460,78255,61889,722109,71464,99957,61860,60373,37757,94142,36552,40455,76554,54950,23161,55558,92359,34950,18954,69552,52453,22245,55752,79956,91660,87659,82959,37577,36280,74974,58880,13684,94894,17083,39779,06676,32981,33679,64792,96887,96791,69377,14579,82192,38490,15384,88578,26860,91263,23756,79221,34616,74016,37014,80147,77152,26156,97957,38959,23573,13484,65978,90186,48276,88079,07483,143178,69178,94890,74992,568119,377219,380214,394
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79,622
74,473
59,818
61,984
60,195
56,841
56,444
49,608
117,744
115,859
109,476
112,503
121,777
114,663
102,684
154,049
153,918
160,828
161,134
177,926
174,200
170,655
170,655174,200177,926161,134160,828153,918154,049102,684114,663121,777112,503109,476115,859117,74449,60856,44456,84160,19561,98459,81874,47379,622000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
10,950
3,356
3,370
3,671
7,563
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
6,581
15,093
14,998
14,903
14,808
14,714
14,619
14,524
14,429
14,334
14,240
14,145
14,050
13,955
13,861
13,766
13,671
13,576
13,482
13,387
13,292
13,872
13,777
56,070
56,704
54,099
79,622
74,473
59,818
61,984
60,195
56,841
56,444
49,608
45,763
43,889
45,791
49,422
65,457
60,531
53,634
0
0
82,108
0
0
0
0
000082,1080053,63460,53165,45749,42245,79143,88945,76349,60856,44456,84160,19561,98459,81874,47379,62254,09956,70456,07013,77713,87213,29213,38713,48213,57613,67113,76613,86113,95514,05014,14514,24014,33414,42914,52414,61914,71414,80814,90314,99815,0936,5810000000000000101000000010000000010000107,5633,6713,3703,35610,95000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,802
9,621
8,430
6,983
6,838
5,333
6,216
4,503
4,060
4,801
8,910
8,932
7,877
8,138
9,281
8,206
7,087
7,264
0
0
13,135
0
0
0
0
000013,135007,2647,0878,2069,2818,1387,8778,9328,9104,8014,0604,5036,2165,3336,8386,9838,4309,62110,802000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
141,353
165,524
167,842
170,842
172,400
176,308
179,672
183,363
185,422
189,220
192,269
196,396
198,347
202,354
205,441
209,393
211,920
232,679
235,181
239,122
241,781
244,892
243,590
249,179
253,232
392,770
366,185
338,654
312,377
313,536
350,630
380,808
388,122
402,254
425,390
389,521
406,042
428,873
427,812
423,997
417,884
422,403
448,696
465,440
487,682
492,835
489,451
485,180
500,233
529,129
538,941
562,974
612,097
643,963
706,223
797,627
734,612
776,084
711,500
740,425
725,857
728,989
774,542
716,112
731,318
707,058
692,023
644,082
654,542
662,561
753,847
740,572
705,203
725,330
738,834
727,611
751,401
742,309
739,861
729,985
746,423
770,916
825,759
823,915
846,668
951,671
995,515
1,004,881
1,000,051
1,001,446
1,038,462
1,083,848
1,083,8481,038,4621,001,4461,000,0511,004,881995,515951,671846,668823,915825,759770,916746,423729,985739,861742,309751,401727,611738,834725,330705,203740,572753,847662,561654,542644,082692,023707,058731,318716,112774,542728,989725,857740,425711,500776,084734,612797,627706,223643,963612,097562,974538,941529,129500,233485,180489,451492,835487,682465,440448,696422,403417,884423,997427,812428,873406,042389,521425,390402,254388,122380,808350,630313,536312,377338,654366,185392,770253,232249,179243,590244,892241,781239,122235,181232,679211,920209,393205,441202,354198,347196,396192,269189,220185,422183,363179,672176,308172,400170,842167,842165,524141,35300
   Retained Earnings 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,203
18,010
23,876
20,478
25,335
27,684
33,754
54,636
49,276
52,520
60,397
68,233
61,311
66,854
75,622
84,526
29,769
35,587
45,350
53,932
51,003
56,073
65,861
74,999
72,222
75,570
114,418
123,494
122,074
129,977
142,007
153,171
151,296
159,991
173,225
184,104
188,190
192,640
206,667
201,553
213,951
220,501
232,014
228,314
236,322
254,302
222,571
224,481
232,476
293,198
311,438
309,736
334,144
345,007
352,520
347,894
357,909
371,239
377,497
388,786
430,158
437,424
467,037
501,507
451,423
458,487
494,541
560,390
560,390494,541458,487451,423501,507467,037437,424430,158388,786377,497371,239357,909347,894352,520345,007334,144309,736311,438293,198232,476224,481222,571254,302236,322228,314232,014220,501213,951201,553206,667192,640188,190184,104173,225159,991151,296153,171142,007129,977122,074123,494114,41875,57072,22274,99965,86156,07351,00353,93245,35035,58729,76984,52675,62266,85461,31168,23360,39752,52049,27654,63633,75427,68425,33520,47823,87618,0103,20300000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,819,516
Cost of Revenue-1,471,962
Gross Profit347,554347,554
 
Operating Income (+$)
Gross Profit347,554
Operating Expense-1,797,098
Operating Income22,418-1,449,544
 
Operating Expense (+$)
Research Development0
Selling General Administrative259,167
Selling And Marketing Expenses0
Operating Expense1,797,098259,167
 
Net Interest Income (+$)
Interest Income13,584
Interest Expense-7,588
Other Finance Cost-631
Net Interest Income5,364
 
Pretax Income (+$)
Operating Income22,418
Net Interest Income5,364
Other Non-Operating Income Expenses0
Income Before Tax (EBT)117,51122,418
EBIT - interestExpense = -7,588
89,275
96,863
Interest Expense7,588
Earnings Before Interest and Taxes (EBIT)0125,099
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax117,511
Tax Provision-28,235
Net Income From Continuing Ops89,27589,275
Net Income89,275
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-5,364
 

Technical Analysis of Shanghai No1 Pharmacy Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai No1 Pharmacy Co Ltd. The general trend of Shanghai No1 Pharmacy Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai No1 Pharmacy Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai No1 Pharmacy Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 14.80 < 14.90 < 15.64.

The bearish price targets are: 13.62 > 13.46 > 11.55.

Tweet this
Shanghai No1 Pharmacy Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai No1 Pharmacy Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai No1 Pharmacy Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShanghai No1 Pharmacy Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai No1 Pharmacy Co Ltd. The current adx is .

Shanghai No1 Pharmacy Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Relative Strength Index (RSI) ChartShanghai No1 Pharmacy Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Stochastic Oscillator ChartShanghai No1 Pharmacy Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Commodity Channel Index (CCI) ChartShanghai No1 Pharmacy Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShanghai No1 Pharmacy Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Williams %R ChartShanghai No1 Pharmacy Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Average True Range (ATR) ChartShanghai No1 Pharmacy Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily On-Balance Volume (OBV) ChartShanghai No1 Pharmacy Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai No1 Pharmacy Co Ltd.

Shanghai No1 Pharmacy Co Ltd Daily Money Flow Index (MFI) ChartShanghai No1 Pharmacy Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai No1 Pharmacy Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Shanghai No1 Pharmacy Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai No1 Pharmacy Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose14.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Shanghai No1 Pharmacy Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shanghai No1 Pharmacy Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai No1 Pharmacy Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai No1 Pharmacy Co Ltd

I send you an email if I find something interesting about Shanghai No1 Pharmacy Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai No1 Pharmacy Co Ltd.

Receive notifications about Shanghai No1 Pharmacy Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.